Wang Y, Zhang L, Wang X
Department of Obstetrics and Gynecology, Third Hospital, Peking University, Beijing 100083, China.
Zhonghua Fu Chan Ke Za Zhi. 2001 Feb;36(2):85-8.
To investigate the abnormal distribution of lymphocytes in eutopic and ectopic endometrium of patients with endometriosis and its significance.
In 43 cases, biopsies of ectopic tissues were taken by laparoscopy and laparotomy from patients with endometriosis and eutopic endometrium by curettage at the same time. In 19 cases, eutopic endometrium was taken from hysterectomy for myomatous uterus. Immunohistochemical techniques were employed to demonstrate the difference in the number and ratio of the lymphocyte subsets between the patients with endometriosis and the controls.
In the patients with endometriosis, in the proliferative phase, ectopic endometrium contained respectively CD3+ CD8+ T cells and CD68+ macrophages (67.2 +/- 13.5)/5 HP, (45.0 +/- 14.0)/5 HP and (37.2 +/- 10.6)/5 HP, significantly higher then that in the eutopic endometrium (52.4 +/- 11.3)/5 HP (P < 0.01), (32.5 +/- 10.0)/5 HP (P < 0.05), and (30.7 +/- 10.3)/5 HP, and also higher as compared with the control group (52.1 +/- 14.9)/5 HP (P < 0.05), (28.9 +/- 12.7)/5 HP (P < 0.01), (26.3 +/- 9.3)/5 HP (P < 0.05); in the secretory phade, CD8+/CD4+, and CD68+ content was respectively 3.5 +/- 1.2, (40.3 +/- 12.2)/5 HP, higher than that in the control group, 3.2 +/- 0.8 (P < 0.05), (28.6 +/- 10.6)/5 HP (P < 0.01). The number of macrophages was also significantly increased. No cyclic changes in the number of lymphocytes in each subpopulation in ectopic endometrium were found.
In the patients with endometriosis, the changes in T lymphocytes and macrophages are mainly on the endometriotic sites. The infiltration of many lymphocytes and macrophages into the ectopic endometrium formed a chronic inflammatory process. The lymphocytes are not able to clear the ectopic endometrium in the late stages of endometrium, on the contrary, they stimulate the further growth of the endometrium.
探讨子宫内膜异位症患者在位及异位内膜中淋巴细胞的异常分布及其意义。
选取43例子宫内膜异位症患者,经腹腔镜和剖腹手术获取异位组织活检标本,同时行诊刮获取在位内膜。选取19例因子宫肌瘤行子宫切除术患者的在位内膜作为对照。采用免疫组织化学技术检测子宫内膜异位症患者与对照组淋巴细胞亚群数量及比例的差异。
子宫内膜异位症患者增殖期,异位内膜中CD3⁺CD8⁺T细胞及CD68⁺巨噬细胞含量分别为(67.2±13.5)/5HP、(45.0±14.0)/5HP和(37.2±10.6)/5HP,显著高于在位内膜[(52.4±11.3)/5HP,P<0.01;(32.5±10.0)/5HP,P<0.05;(30.7±10.3)/5HP],也高于对照组[(52.1±14.9)/5HP,P<0.05;(28.9±12.7)/5HP,P<0.01;(26.3±9.3)/5HP,P<0.05];分泌期,CD8⁺/CD4⁺及CD68⁺含量分别为3.5±1.2、(40.3±12.2)/5HP,高于对照组[3.2±0.8,P<0.05;(28.6±10.6)/5HP,P<0.01]。巨噬细胞数量也显著增加。异位内膜各亚群淋巴细胞数量无周期性变化。
子宫内膜异位症患者T淋巴细胞和巨噬细胞的变化主要发生在异位内膜部位。大量淋巴细胞和巨噬细胞浸润异位内膜形成慢性炎症过程。淋巴细胞在子宫内膜后期无法清除异位内膜,反而刺激内膜进一步生长。